Cellular Longevity, Inc. — Form D
Cellular Longevity, Inc. of SAN FRANCISCO, CA, a company, filed a Form D exempt-offering notice with the SEC on 2021-06-25. The offering totals $4.0M, of which $832K was reported sold. Industry: Biotechnology.
Offering
- Filed: 2021-06-25
- Form: D
- Accession: 0001799919-21-000004
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $4.0M
- Amount sold: $832K
- Remaining: $3.2M
- Investors: 10
- Date of first sale: 2020-12-17
- Revenue range: Decline to Disclose
- SEC file number: 021-404236
Issuer
- Name: Cellular Longevity, Inc.
- CIK: 0001799919
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2019
- Address: 548 MARKET STREET, SUITE #26099, SAN FRANCISCO, CA, 94104
- Phone: 408-757-0450
Officers, directors & promoters (6)
| Name | Role | Location |
|---|
| Laura Deming | Director | San Francisco, CA |
| Linda Rhodes | Director | San Francisco, CA |
| Celine-Lea Halioua-Haubold | Director | San Francisco, CA |
| Celine-Lea Halioua-Haubold | Executive Officer | San Francisco, CA |
| Kevin Zhang | Director | Los Angeles, CA |
| Blake Scholl | Director | San Francisco, CA |
Other filings by this issuer (5)
More